Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob M Rowe

Showing results (121-130 of 275) with videos related to

Pageof 28
Sort By:
Acta Haematologica|December 20, 2011
The increased risk for pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim/sulfamethoxazole: a single-center experienceEmilia Hardak, Ilana Oren, Eldad J Dann, et al.
Human Reproduction (Oxford, England)|April 9, 2005
Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphomaEldad J Dann, Ron Epelbaum, Irit Avivi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2013
Single infusion of donor mononuclear early apoptotic cells as prophylaxis for graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation: a phase I/IIa clinical trialDror Mevorach, Tsila Zuckerman, Inna Reiner, et al.
American Journal of Hematology|February 21, 2013
Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab eraIrit Avivi, Ariel Zilberlicht, Eldad J Dann, et al.
Blood|March 8, 2017
Published abstracts at international meetings often over- or underestimate the initial response rateOfrat Beyar-Katz, Jacob M Rowe, Lauren E Townsend, et al.
Hematological Oncology|January 14, 2012
Imatinib plasma trough levels in chronic myeloid leukaemia: results of a multicentre study CSTI571AIL11TGLIVECMaya Koren-Michowitz, Yulia Volchek, Elizabeth Naparstek, et al.
British Journal of Haematology|January 25, 2003
Granulocyte colony-stimulating factor administration upregulates telomerase activity in CD34+ haematopoietic cells and may prevent telomere attrition after chemotherapyMartine Szyper-Kravitz, Orit Uziel, Hava Shapiro, et al.
Haematologica|May 7, 2011
Leukemia-free survival as a surrogate end point for overall survival in the evaluation of maintenance therapy for patients with acute myeloid leukemia in complete remissionMarc Buyse, Stefan Michiels, Pierre Squifflet, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Phase II study of interleukin-4 in indolent B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E5Y92)Peter H Wiernik, Janice P Dutcher, Xiapan Yao, et al.
Haematologica|April 23, 2010
A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphomaEldad J Dann, Rachel Bar-Shalom, Ada Tamir, et al.
Pageof 28

Showing results (121-130 of 275) with videos related to

Sort By:
Pageof 28
Acta Haematologica|December 20, 2011
The increased risk for pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim/sulfamethoxazole: a single-center experienceEmilia Hardak, Ilana Oren, Eldad J Dann, et al.
Human Reproduction (Oxford, England)|April 9, 2005
Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphomaEldad J Dann, Ron Epelbaum, Irit Avivi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2013
Single infusion of donor mononuclear early apoptotic cells as prophylaxis for graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation: a phase I/IIa clinical trialDror Mevorach, Tsila Zuckerman, Inna Reiner, et al.
American Journal of Hematology|February 21, 2013
Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab eraIrit Avivi, Ariel Zilberlicht, Eldad J Dann, et al.
Blood|March 8, 2017
Published abstracts at international meetings often over- or underestimate the initial response rateOfrat Beyar-Katz, Jacob M Rowe, Lauren E Townsend, et al.
Hematological Oncology|January 14, 2012
Imatinib plasma trough levels in chronic myeloid leukaemia: results of a multicentre study CSTI571AIL11TGLIVECMaya Koren-Michowitz, Yulia Volchek, Elizabeth Naparstek, et al.
British Journal of Haematology|January 25, 2003
Granulocyte colony-stimulating factor administration upregulates telomerase activity in CD34+ haematopoietic cells and may prevent telomere attrition after chemotherapyMartine Szyper-Kravitz, Orit Uziel, Hava Shapiro, et al.
Haematologica|May 7, 2011
Leukemia-free survival as a surrogate end point for overall survival in the evaluation of maintenance therapy for patients with acute myeloid leukemia in complete remissionMarc Buyse, Stefan Michiels, Pierre Squifflet, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Phase II study of interleukin-4 in indolent B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E5Y92)Peter H Wiernik, Janice P Dutcher, Xiapan Yao, et al.
Haematologica|April 23, 2010
A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphomaEldad J Dann, Rachel Bar-Shalom, Ada Tamir, et al.
Pageof 28